Dijkman, Karin
Lindenstrøm, Thomas http://orcid.org/0000-0002-7162-8124
Rosenkrands, Ida
Søe, Rikke
Woodworth, Joshua S. http://orcid.org/0000-0002-0771-9056
Lindestam Arlehamn, Cecilia S. http://orcid.org/0000-0001-7302-8002
Mortensen, Rasmus http://orcid.org/0000-0003-0177-3032
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI135721)
Article History
Received: 24 November 2022
Accepted: 25 April 2023
First Online: 9 May 2023
Competing interests
: R.M. is co-inventor of a patent covering the use of H107 and derivatives. I.R. is co-inventor of patents covering the use of CAF®01 as an adjuvant. All rights have been assigned to Statens Serum Institut. The remaining authors declare no competing interests. This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (Grant R01AI135721).